Zobrazeno 1 - 10
of 75
pro vyhledávání: ''
Autor:
L. Michaud, Françoise Montravers, Jean-Noël Talbot, Sona Balogova, Virginie Huchet, Valérie Nataf, Khaldoun Kerrou
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging
6-Fluoro-((18)F)-L-3,4-dihydroxyphenylalanine (FDOPA) is an amino acid analogue for positron emission tomography (PET) imaging which has been registered since 2006 in several European Union (EU) countries and by several pharmaceutical firms. Neuroend
Publikováno v:
Journal of Nuclear Cardiology. 19(4):681-692
Adenosine receptor stress agents for myocardial perfusion imaging (MPI) may cause A(2B) and/or A(3) receptor-mediated bronchoconstriction, of particular concern to physicians testing patients with asthma or chronic obstructive pulmonary disease (COPD
Autor:
Nicholas Screaton, Pauline T. Lukey, Robert I. Shortman, Brian Hutton, Raymondo Endozo, Tryphon Lambrou, Peter J. Ell, Ashley M. Groves, Thida Win, Toby M. Maher, Asim Afaq, Joanna C. Porter, Benjamin A. Thomas
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging
Purpose Patients with idiopathic pulmonary fibrosis (IPF) show increased PET signal at sites of morphological abnormality on high-resolution computed tomography (HRCT). The purpose of this investigation was to investigate the PET signal at sites of n
Publikováno v:
Skovgaard, D, Persson, M & Kjaer, A 2016, ' PET imaging of urokinase-type plasminogen activator receptor (uPAR) in prostate cancer : current status and future perspectives ', Clinical and Translational Imaging, vol. 4, no. 6, pp. 457-465 . https://doi.org/10.1007/s40336-016-0197-4
Clinical and Translational Imaging
Clinical and Translational Imaging
Overexpression of urokinase-type plasminogen activator receptors (uPAR) represents an important biomarker for aggressiveness in most common malignant diseases, including prostate cancer (PC). Accordingly, uPAR expression either assessed directly in m
Autor:
Walter Coudyzer, Martin Schwarz, Jean-Pierre Lestrat, Sam Heye, Jean-François Heautot, Johan De Mey, Christoph R. Becker, Melanie Schernthaner, Johannes Lammer, Riccardo Berletti, Jérôme Caudron, Carlo Alberto Cametti, Massimo Favat, Koenraad Nieboer, Roberto Marangoni, Christian Loewe, A. Larralde, Markus Hittinger, Peter Reimer
Publikováno v:
European Radiology
Purpose The purpose of this study was to assess the influence of iodine concentration on diagnostic efficacy in multi-detector-row computed tomography (MDCT) angiography of the abdominal aorta and abdominal arteries. Methods IRB approval and informed
Publikováno v:
Abdominal Imaging
Objective: To assess the feasibility and effectiveness of transjugular intrahepatic route aspiration thrombectomy and catheter-directed thrombolytic therapy in patients with acute superior mesenteric venous thrombosis. Materials and methods: During a
Autor:
E. E. van der Wall
Publikováno v:
The International Journal of Cardiovascular Imaging. 25(3):285-288
Over the past years cardiovascular magnetic resonance (CMR) imaging has been increasingly used to detect the presence of coronary artery disease and to assess its functional consequences to the myocardium [1]. Several approaches have been applied to
Publikováno v:
European Radiology
Objective The biodistribution of gadolinium (Gd) and chelate was studied in rats injected intravenously with a commercially available gadodiamide magnetic resonance contrast agent spiked with trace amounts of 14C-labelled GdDTPA-BMA. Methods Biodistr
Publikováno v:
Journal of Nuclear Cardiology
Background The effect of beta blockers on myocardial blood flow (MBF) under vasodilators has been studied in several SPECT and PET myocardial perfusion imaging (MPI) studies with divergent results. The present study evaluated the effect of a beta blo
Autor:
Michael Lin, Mark T Lee, Myo Min, Victoria J Bray, Ivan Ho Shon, Peter Lin, Dion Forstner, Andrew Chicco, Minh Thi Tieu, Allan Fowler
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging
Purpose To evaluate the prognostic value of 18F-FDG PET-CT performed in the third week (iPET) of definitive radiation therapy (RT) in patients with newly diagnosed locally advanced mucosal primary head and neck squamous-cell-carcinoma (MPHNSCC). Meth